Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Diabetes

  Free Subscription


Articles published in Metabolism

Retrieve available abstracts of 57 articles:
HTML format
Text format



Single Articles


    May 2017
  1. MONGRAW-CHAFFIN M, LaCroix AZ, Sears DD, Garcia L, et al
    A prospective study of low fasting glucose with cardiovascular disease events and all-cause mortality: The Women's Health Initiative.
    Metabolism. 2017;70:116-124.
    PubMed     Text format     Abstract available


    April 2017
  2. NATALI A, Baldi S, Bonnet F, Petrie J, et al
    Plasma HDL-cholesterol and triglycerides, but not LDL-cholesterol, are associated with insulin secretion in non-diabetic subjects.
    Metabolism. 2017;69:33-42.
    PubMed     Text format     Abstract available


    March 2017
  3. KRALISCH S, Hoffmann A, Lossner U, Kratzsch J, et al
    Regulation of the novel adipokines/ hepatokines fetuin A and fetuin B in gestational diabetes mellitus.
    Metabolism. 2017;68:88-94.
    PubMed     Text format     Abstract available


  4. CARDOSO L, Vicente N, Rodrigues D, Gomes L, et al
    Controversies in the management of hyperglycaemic emergencies in adults with diabetes.
    Metabolism. 2017;68:43-54.
    PubMed     Text format     Abstract available


  5. GOMES JM, Costa JA, Alfenas RC
    Metabolic endotoxemia and diabetes mellitus: A systematic review.
    Metabolism. 2017;68:133-144.
    PubMed     Text format     Abstract available


    January 2017
  6. GOLDBERG RB, Temprosa M, Mele L, Orchard T, et al
    Erratum to: "Change in adiponectin explains most of the change in HDL particles induced by lifestyle intervention but not metformin treatment in the diabetes prevention program" [Metabolism (2016) 65; 764-775].
    Metabolism. 2017 Jan 5. pii: S0026-0495(16)30165.
    PubMed     Text format    


  7. FARR OM, Mantzoros CS
    WITHDRAWN: Treatment options to prevent diabetes in subjects with prediabetes: efficacy, cost effectiveness and future outlook.
    Metabolism. 2017 Jan 4. pii: S0026-0495(17)30001.
    PubMed     Text format     Abstract available


  8. SIDDIQUI F, Kurbasic A, Lindblad U, Nilsson PM, et al
    Effects of a culturally adapted lifestyle intervention on cardio-metabolic outcomes: a randomized controlled trial in Iraqi immigrants to Sweden at high risk for Type 2 diabetes.
    Metabolism. 2017;66:1-13.
    PubMed     Text format     Abstract available


    December 2016
  9. PEREIRA MJ, Skrtic S, Katsogiannos P, Abrahamsson N, et al
    Impaired adipose tissue lipid storage, but not altered lipolysis, contributes to elevated levels of NEFA in type 2 diabetes. Degree of hyperglycemia and adiposity are important factors.
    Metabolism. 2016;65:1768-1780.
    PubMed     Text format     Abstract available


  10. ZHAO WN, Xu SQ, Liang JF, Peng L, et al
    Endothelial progenitor cells from human fetal aorta cure diabetic foot in a rat model.
    Metabolism. 2016;65:1755-1767.
    PubMed     Text format     Abstract available


  11. JOY NG, Mikeladze M, Younk LM, Tate DB, et al
    Effects of equivalent sympathetic activation during hypoglycemia on endothelial function and pro-atherothrombotic balance in healthy individuals and obese standard treated type 2 diabetes.
    Metabolism. 2016;65:1695-1705.
    PubMed     Text format     Abstract available


    November 2016
  12. CHOE EY, Wang HJ, Kwon O, Kim KJ, et al
    Corrigendum to "Variants of the adiponectin gene and diabetic microvascular complications in patients with type 2 diabetes" [Metab. Clin. Exp. 62 (2013) 677-685].
    Metabolism. 2016 Nov 29. pii: S0026-0495(16)30151.
    PubMed     Text format    


    October 2016
  13. KOWLURU RA, Mishra M, Kowluru A, Kumar B, et al
    Hyperlipidemia and the development of diabetic retinopathy: Comparison between type 1 and type 2 animal models.
    Metabolism. 2016;65:1570-81.
    PubMed     Text format     Abstract available


  14. HAN E, Kim MS, Kim YS, Kang ES, et al
    Risk assessment and management of post-transplant diabetes mellitus.
    Metabolism. 2016;65:1559-69.
    PubMed     Text format     Abstract available


  15. HAN E, Lee YH, Kim G, Kim SR, et al
    Sarcopenia is associated with albuminuria independently of hypertension and diabetes: KNHANES 2008-2011.
    Metabolism. 2016;65:1531-40.
    PubMed     Text format     Abstract available


  16. BRUTSAERT EF, Biggs ML, Delaney JA, Djousse L, et al
    Longitudinal assessment of N-terminal pro-B-type natriuretic peptide and risk of diabetes in older adults: The cardiovascular health study.
    Metabolism. 2016;65:1489-97.
    PubMed     Text format     Abstract available


  17. TUNCDEMIR M, Ozturk M
    Regulation of the Ku70 and apoptosis-related proteins in experimental diabetic nephropathy.
    Metabolism. 2016;65:1466-77.
    PubMed     Text format     Abstract available


    September 2016
  18. MANJUNATHA S, Distelmaier K, Dasari S, Carter RE, et al
    Functional and proteomic alterations of plasma high density lipoproteins in type 1 diabetes mellitus.
    Metabolism. 2016;65:1421-31.
    PubMed     Text format     Abstract available


  19. CARTER TC, Rein D, Padberg I, Peter E, et al
    Validation of a metabolite panel for early diagnosis of type 2 diabetes.
    Metabolism. 2016;65:1399-408.
    PubMed     Text format     Abstract available


  20. YANG P, Huang T, Xu G
    The novel mineralocorticoid receptor antagonist finerenone in diabetic kidney disease: Progress and challenges.
    Metabolism. 2016;65:1342-9.
    PubMed     Text format    


  21. KARSTOFT K, Wallis GA, Pedersen BK, Solomon TP, et al
    The effects of interval- vs. continuous exercise on excess post-exercise oxygen consumption and substrate oxidation rates in subjects with type 2 diabetes.
    Metabolism. 2016;65:1316-25.
    PubMed     Text format     Abstract available


  22. PERAKAKIS N, Mantzoros CS
    Immune therapy in type 1 diabetes mellitus - Attempts to untie the Gordian knot?
    Metabolism. 2016;65:1278-85.
    PubMed     Text format    


  23. ZHANG X, Xing S, Li M, Zhang L, et al
    Beyond knockout: A novel homodimerization-targeting MyD88 inhibitor prevents and cures type 1 diabetes in NOD mice.
    Metabolism. 2016;65:1267-77.
    PubMed     Text format     Abstract available


  24. YOO HJ, Choi KM, Baik SH, Park JH, et al
    Influences of body size phenotype on the incidence of gestational diabetes needing prescription; analysis by Korea National Health Insurance (KNHI) claims and the National Health Screening Examination (NHSE) database.
    Metabolism. 2016;65:1259-66.
    PubMed     Text format     Abstract available


    July 2016
  25. FRYK E, Sundelin JP, Strindberg L, Pereira MJ, et al
    Microdialysis and proteomics of subcutaneous interstitial fluid reveals increased galectin-1 in type 2 diabetes patients.
    Metabolism. 2016;65:998-1006.
    PubMed     Text format     Abstract available


  26. STARUP-LINDE J, Gejl M, Borghammer P, Knop FK, et al
    Vagotomy and subsequent development of diabetes - A nested case-control study.
    Metabolism. 2016;65:954-60.
    PubMed     Text format     Abstract available


    June 2016
  27. LI JJ, Wittert GA, Vincent A, Atlantis E, et al
    Muscle grip strength predicts incident type 2 diabetes: Population-based cohort study.
    Metabolism. 2016;65:883-92.
    PubMed     Text format     Abstract available


  28. WANG P, Yang X, Zhang Z, Song J, et al
    Depletion of NAD pool contributes to impairment of endothelial progenitor cell mobilization in diabetes.
    Metabolism. 2016;65:852-62.
    PubMed     Text format     Abstract available


  29. PARK CY, Park JY, Choi J, Kim DJ, et al
    Increased postprandial apolipoprotein B-48 level after a test meal in diabetic patients: A multicenter, cross-sectional study.
    Metabolism. 2016;65:843-51.
    PubMed     Text format     Abstract available


  30. QIU S, Cai X, Yin H, Zugel M, et al
    Association between circulating irisin and insulin resistance in non-diabetic adults: A meta-analysis.
    Metabolism. 2016;65:825-34.
    PubMed     Text format     Abstract available


  31. MONTEIRO MB, Thieme K, Santos-Bezerra DP, Queiroz MS, et al
    Beta-2-microglobulin (B2M) expression in the urinary sediment correlates with clinical markers of kidney disease in patients with type 1 diabetes.
    Metabolism. 2016;65:816-24.
    PubMed     Text format     Abstract available


    May 2016
  32. WILLIAMS KH, Sullivan DR, Nicholson GC, George J, et al
    Opposite associations between alanine aminotransferase and gamma-glutamyl transferase levels and all-cause mortality in type 2 diabetes: Analysis of the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study.
    Metabolism. 2016;65:783-93.
    PubMed     Text format     Abstract available


  33. GOLDBERG RB, Temprosa M, Mele L, Orchard T, et al
    Change in adiponectin explains most of the change in HDL particles induced by lifestyle intervention but not metformin treatment in the Diabetes Prevention Program.
    Metabolism. 2016;65:764-75.
    PubMed     Text format     Abstract available


  34. CHANG E, Abe J
    Kinase-SUMO networks in diabetes-mediated cardiovascular disease.
    Metabolism. 2016;65:623-33.
    PubMed     Text format     Abstract available


  35. TERADA T, Wilson BJ, Myette-Comicronte E, Kuzik N, et al
    Targeting specific interstitial glycemic parameters with high-intensity interval exercise and fasted-state exercise in type 2 diabetes.
    Metabolism. 2016;65:599-608.
    PubMed     Text format     Abstract available


  36. TER HORST KW, Gilijamse PW, Ackermans MT, Soeters MR, et al
    Impaired insulin action in the liver, but not in adipose tissue or muscle, is a distinct metabolic feature of impaired fasting glucose in obese humans.
    Metabolism. 2016;65:757-63.
    PubMed     Text format     Abstract available


  37. SAHEBKAR A, Hernandez-Aguilera A, Abello D, Sancho E, et al
    Systematic review and meta-analysis deciphering the impact of fibrates on paraoxonase-1 status.
    Metabolism. 2016;65:609-22.
    PubMed     Text format     Abstract available


    April 2016
  38. BASOULIS D, Fragiadaki K, Tentolouris N, Sfikakis PP, et al
    Anti-TNFalpha treatment for recalcitrant ulcerative necrobiosis lipoidica diabeticorum: A case report and review of the literature.
    Metabolism. 2016;65:569-73.
    PubMed     Text format     Abstract available


  39. NYENWE EA, Kitabchi AE
    The evolution of diabetic ketoacidosis: An update of its etiology, pathogenesis and management.
    Metabolism. 2016;65:507-21.
    PubMed     Text format     Abstract available


  40. NIU Y, Zhang W, Yang Z, Li X, et al
    Plasma osteoprotegerin levels are inversely associated with nonalcoholic fatty liver disease in patients with type 2 diabetes: A case-control study in China.
    Metabolism. 2016;65:475-81.
    PubMed     Text format     Abstract available


  41. HUANG Q, Chen Y, Gong N, Wang YX, et al
    Methylglyoxal mediates streptozotocin-induced diabetic neuropathic pain via activation of the peripheral TRPA1 and Nav1.8 channels.
    Metabolism. 2016;65:463-74.
    PubMed     Text format     Abstract available


  42. BAUM P, Kosacka J, Estrela-Lopis I, Woidt K, et al
    The role of nerve inflammation and exogenous iron load in experimental peripheral diabetic neuropathy (PDN).
    Metabolism. 2016;65:391-405.
    PubMed     Text format     Abstract available


    March 2016
  43. SYNGELAKI A, Visser GH, Krithinakis K, Wright A, et al
    First trimester screening for gestational diabetes mellitus by maternal factors and markers of inflammation.
    Metabolism. 2016;65:131-7.
    PubMed     Text format     Abstract available


  44. KAMPMANN K, Ueberberg S, Menge BA, Breuer TG, et al
    Abundance and turnover of GLP-1 producing L-cells in ileal mucosa are not different in patients with and without type 2 diabetes.
    Metabolism. 2016;65:84-91.
    PubMed     Text format     Abstract available


  45. BANCKS MP, Bielinski SJ, Decker PA, Hanson NQ, et al
    Circulating level of hepatocyte growth factor predicts incidence of type 2 diabetes mellitus: The Multi-Ethnic Study of Atherosclerosis (MESA).
    Metabolism. 2016;65:64-72.
    PubMed     Text format     Abstract available


  46. INOUE Y, Kawai M, Minai K, Ogawa K, et al
    The impact of an inverse correlation between plasma B-type natriuretic peptide levels and insulin resistance on the diabetic condition in patients with heart failure.
    Metabolism. 2016;65:38-47.
    PubMed     Text format     Abstract available


  47. KIMURA S, Inoguchi T, Yamasaki T, Yamato M, et al
    A novel DPP-4 inhibitor teneligliptin scavenges hydroxyl radicals: In vitro study evaluated by electron spin resonance spectroscopy and in vivo study using DPP-4 deficient rats.
    Metabolism. 2016;65:138-45.
    PubMed     Text format     Abstract available


    February 2016
  48. LEBKOWSKA A, Adamska A, Karczewska-Kupczewska M, Nikolajuk A, et al
    Serum anti-Mullerian hormone concentration in women with polycystic ovary syndrome and type 1 diabetes mellitus.
    Metabolism. 2016 Feb 16. pii: S0026-0495(16)00036.
    PubMed     Text format     Abstract available


  49. GOULIS DG
    Presence of type 1 diabetes in women with polycystic ovary syndrome: Does it have any impact on anti-Mullerian hormone concentrations?
    Metabolism. 2016 Feb 16. pii: S0026-0495(16)00035.
    PubMed     Text format    


  50. GAO F, Zhang X, Zhou L, Zhou S, et al
    Type 2 diabetes mitigation in the diabetic Goto-Kakizaki rat by elevated bile acids following a common-bile-duct surgery.
    Metabolism. 2016;65:78-88.
    PubMed     Text format     Abstract available


  51. MOHAMMEDI K, Patente TA, Bellili-Munoz N, Driss F, et al
    Glutathione peroxidase-1 gene (GPX1) variants, oxidative stress and risk of kidney complications in people with type 1 diabetes.
    Metabolism. 2016;65:12-9.
    PubMed     Text format     Abstract available


    January 2016
  52. HAZLEHURST JM, Woods C, Marjot T, Cobbold JF, et al
    Non-alcoholic fatty liver disease and diabetes.
    Metabolism. 2016 Jan 11. pii: S0026-0495(16)00004.
    PubMed     Text format     Abstract available


  53. LAMPROPOULOU E, Lymperopoulou A, Charonis A
    Reduced expression of ERp46 under diabetic conditions in beta-cells and the effect of liraglutide.
    Metabolism. 2016;65:7-15.
    PubMed     Text format     Abstract available


  54. LUNATI ME, Grancini V, Colombo C, Palmieri E, et al
    Basal and stimulated calcitonin levels in patients with type 2 diabetes did not change during 1year of Liraglutide treatment.
    Metabolism. 2016;65:1-6.
    PubMed     Text format     Abstract available


  55. KIM Y, Keogh J, Clifton PM
    Response to the comment by Kuipers and Pruiboom.
    Metabolism. 2016;65:e5.
    PubMed     Text format    


    December 2015
  56. LIANG Y, Yuan W, Zhu W, Zhu J, et al
    Macrophage migration inhibitory factor promotes expression of GLUT4 glucose transporter through MEF2 and Zac1 in cardiomyocytes.
    Metabolism. 2015;64:1682-93.
    PubMed     Text format     Abstract available


    October 2015
  57. AGARWAL I, Glazer NL, Barasch E, Djousse L, et al
    Associations between metabolic dysregulation and circulating biomarkers of fibrosis: the Cardiovascular Health Study.
    Metabolism. 2015;64:1316-23.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Diabetes is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: